Atomoxetine is used to treat attention-deficit hyperactivity disorder (ADHD) as part of a total treatment plan, including psychological, social, and other treatments. It may help to increase the ability to pay attention, concentrate, stay focused, and stop fidgeting.

Strattera (atomoxetine) is a brand-name oral capsule that's prescribed for attention deficit hyperactivity disorder (ADHD). As with other drugs, Strattera can cause side effects, such as nausea, decreased appetite, and drowsiness.

Stimulant medications like Adderall are known to be the most effective treatment for ADHD. As such, they are considered first-line medication. Non-stimulant medications like Strattera are second-line medications. While not as effective as stimulants, they can still be effective for ADHD symptoms.

Strattera can increase the risk of death in children and adolescents with existing heart problems, though this is rare. This includes structural heart problems, cardiomyopathy, and heart rhythm problems (arrhythmias). Cases of heart attack, stroke, and death have been reported in adults taking Strattera.